Walleye Capital LLC Cara Therapeutics, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.67 - $3.33 $5,629 - $11,225	-3,371 Reduced 2.4%	137,021 $230,000
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $397,309 - $693,536	140,392 New	140,392 $397,000
Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $287,098 - $437,615	34,842 New	34,842 $326,000
Q1 2020 May 15, 2020	SELL	$9.12 - $17.78 $96,580 - $188,290	-10,590 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.11 - $25.98 $170,604 - $275,128	10,590 New	10,590 $171,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.